Page 1774 - Cote clinical veterinary advisor dogs and cats 4th
P. 1774

Rocky Mountain Spotted Fever   891


           •  Rhinoscopy (p. 1159) findings are variable   •  Anecdotal  reports  of  benefit  for  other    PROGNOSIS & OUTCOME
             and can include                    immunosuppressive or immunomodulatory   •  Cure is uncommon, and mild to moderate
  VetBooks.ir  ○   Mucosal hyperemia            ○   Oclacitinib 0.4-0.6 mg/kg PO q 12h for   •  Maintenance therapy is generally successful in   Diseases and   Disorders
                                                agents
             ○   Copious, thick mucus or mucopurulent
               discharge
                                                                                    clinical signs often persist despite treatment.
                                                  2 weeks, then q 24h (dogs)
             ○   Proliferative or thickened nasal mucosa
                                                                                    are common if treatment is discontinued.
                                                  10-14  days,  then  q  48h  (dogs  only),
             ○   Turbinate lysis or remodeling  ○   Azathioprine  1-2 mg/kg  PO  q  24h  for     minimizing clinical signs, although relapses
             ○   Pseudopolypoid appearance of mucosa  or                          •  Some cases remain refractory to any treat-
             ○   Absence of other causes of nasal discharge   ○   Cyclosporine  3-5  mg/kg  PO  q  12-24h   ment,  although  the  disease  is  rarely  life-
               (e.g.,  neoplasia,  aspergillosis,  foreign   for 2-4 weeks and then q 48h; monitor   threatening.
               bodies)                            serum concentrations            •  Owners should prevent their pets’ exposure
           •  Histopathologic  exam  of  nasal  mucosal   •  Antihistamines are rarely effective but may   to exacerbating factors (e.g., cigarette smoke,
             biopsies is necessary for diagnosis of LPR   reduce discharge in some pets.  perfumes).
             and demonstrates mild to severe lymphoplas-  •  Mucolytic drugs
             macytic infiltration sometimes mixed with   ○   N-acetylcysteine  5-10  mg  PO  q  12h,    PEARLS & CONSIDERATIONS
             mild neutrophilic or eosinophilic infiltration.  up  to  100  mg/kg  PO  q  12h  has  been
                                                  reported.  Intranasal  or  aerosol  delivery   Comments
            TREATMENT                             of 5%-20% solution q 8-12h has been   •  Diagnosis  of  LPR  is  established  by  elimi-
                                                  described. N-acetylcysteine aerosol therapy   nation of other causes of chronic lympho-
           Treatment Overview                     is contraindicated in cats because it can   plasmacytic  nasal  infiltrates.  Referral  for
           Treatment  can  be  challenging.  There  is  no   induce bronchospasm.   advanced imaging can be extremely useful
           therapy that has been proven consistently   ○   Bromhexine hydrochloride 0.5-2 mg/kg   in ruling out other conditions.
           effective for all patients.            PO q 12-24h or through aerosol delivery  •  The disease is chronic and progressive, and
                                                ○   Flushing and aspiration of all nasal secre-  cure is rarely achieved.
           Acute General Treatment                tions during rhinoscopy can help before   •  There is no therapeutic gold standard. Treat-
           •  Generally, antibiotics are of little benefit.  initiating therapy.    ment trials should be used to determine what
             ○   Anecdotally, azithromycin or doxycycline                           works best for each case.
               has been helpful in some cases.  Chronic Treatment
             ○   Some cats respond to repeated courses   •  Humidification of nasal cavities with saline   Technician Tips
               of  amoxicillin,  likely  as  treatment  for   (drops or aerosol delivery) to moisten and   Nebulization of nasal cavities with saline q 8-
               secondary bacterial rhinitis.    help clear nasal secretions.      12h can help moisten and clear nasal secretions.
           •  Glucocorticoids are useful in some, but not   •  Mucolytic drugs (as above)
             all, dogs and cats.               •  Long-term  glucocorticoids  (oral  or   Client Education
             ○   Prednisone 1-2 mg/kg PO q 12-24h for   topical),  potentially  in  combination  with   •  Owner  should  be  warned  that  this  is  a
               7-10  days,  tapered  to  lowest  dose  that   cyclosporine  or  azathioprine;  use  lowest     frustrating condition to treat. Cure is rare,
               controls clinical signs (or until switched   therapeutic dose        but trial and error often allows identification
               to topical corticosteroids)     •  Desensitization therapy according to allergy   of a regimen that can minimize clinical signs.
             ○   If  systemic  glucocorticoids  improve   testing has been anecdotally helpful in a few   •  Treatment must be sustained because relapses
               condition, may switch to topical (nasal   dogs.                      are common.
               spray, drops, or aerosols) treatments (e.g.,                       •  Potentially  exacerbating  factors  should  be
               fluticasone propionate 125-250 mcg q   Possible Complications        avoided.
               12h nasal spray or metered-dose inhaler;   •  Secondary bacterial rhinitis
               prednisolone ophthalmic drops 2 drops   •  Chronic sinusitis       SUGGESTED READING
               per nostril q 12h)                                                 Lobetti  R:  Idiopathic  lymphoplasmacytic  rhinitis
           •  Anecdotal reports of benefit for other anti-  Recommended Monitoring  in 33 dogs. J S Afr Vet Assoc 85(1):1151, 2014.
             inflammatory agents; piroxicam 0.3 mg/kg   Identify and treat episodes of secondary bacterial
             PO q 24h                          rhinitis.                          AUTHOR: Frédéric Billen, DVM, MS, PhD, DECVIM
                                                                                  EDITOR: Megan Grobman, DVM, MS, DACVIM






            Rocky Mountain Spotted Fever                                                           Client Education
                                                                                                          Sheet

            BASIC INFORMATION                  •  Young  dogs  (<2 years) are at greater    CONTAGION AND ZOONOSIS
                                                risk.                             Direct transmission does not occur from dogs
           Definition                                                             to people. Dogs are short-term reservoirs and
           An acute, potentially life-threatening, tick-borne   GENETICS, BREED PREDISPOSITION  sentinels.
           rickettsial disease affecting dogs and people  Purebred dogs, especially German shepherds,
                                               may be predisposed.                GEOGRAPHY AND SEASONALITY
           Epidemiology                                                           Rocky Mountain spotted fever (RMSF) is found in
           SPECIES, AGE, SEX                   RISK FACTORS                       North, Central, and South America. The majority
           •  Species:  dogs  and  people  are  primarily   Tick exposure, failure to use tick preventatives  of cases in the United States occur in the southeast,
             affected. Seropositive cats are not clinically                       south  central,  and  mid-Atlantic  states;  disease
             ill.                                                                 occurrence is highest from March to October.

                                                      www.ExpertConsult.com
   1769   1770   1771   1772   1773   1774   1775   1776   1777   1778   1779